NM_144772.3:c.196C>T
Variant names: 
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_144772.3(NAXE):c.196C>T(p.Gln66*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000105 in 1,614,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
 Genomes: 𝑓 0.0000066   (  0   hom.,  cov: 34) 
 Exomes 𝑓:  0.000011   (  0   hom.  ) 
Consequence
 NAXE
NM_144772.3 stop_gained
NM_144772.3 stop_gained
Scores
 4
 2
 1
Clinical Significance
Conservation
 PhyloP100:  5.92  
Publications
3 publications found 
Genes affected
 NAXE  (HGNC:18453):  (NAD(P)HX epimerase) The product of this gene interacts with apolipoprotein A-I (apoA-I), the major apolipoprotein of high-density lipoproteins (HDLs). It is secreted into some bodily fluids, and its synthesis and secretion are stimulated in vitro by incubating cells with apoA-I. The human genome contains related pseudogenes. [provided by RefSeq, Jul 2008] 
NAXE Gene-Disease associations (from GenCC):
- Leigh syndromeInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Pathogenic. The variant received 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease. 
PM2
Very rare variant in population databases, with high coverage; 
PP5
Variant 1-156592114-C-T is Pathogenic according to our data. Variant chr1-156592114-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 268117.Status of the report is no_assertion_criteria_provided, 0 stars. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.00000657  AC: 1AN: 152246Hom.:  0  Cov.: 34 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1
AN: 
152246
Hom.: 
Cov.: 
34
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000199  AC: 5AN: 251422 AF XY:  0.0000221   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
5
AN: 
251422
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000109  AC: 16AN: 1461874Hom.:  0  Cov.: 83 AF XY:  0.00000963  AC XY: 7AN XY: 727244 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
16
AN: 
1461874
Hom.: 
Cov.: 
83
 AF XY: 
AC XY: 
7
AN XY: 
727244
show subpopulations 
African (AFR) 
 AF: 
AC: 
2
AN: 
33480
American (AMR) 
 AF: 
AC: 
0
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86250
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53414
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
14
AN: 
1112006
Other (OTH) 
 AF: 
AC: 
0
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.450 
Heterozygous variant carriers
 0 
 1 
 2 
 3 
 4 
 5 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00000657  AC: 1AN: 152246Hom.:  0  Cov.: 34 AF XY:  0.0000134  AC XY: 1AN XY: 74384 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
GnomAD4 genome 
 AF: 
AC: 
1
AN: 
152246
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
1
AN XY: 
74384
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
1
AN: 
41470
American (AMR) 
 AF: 
AC: 
0
AN: 
15288
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5194
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4834
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10628
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
314
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68042
Other (OTH) 
 AF: 
AC: 
0
AN: 
2094
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.225 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ExAC 
 AF: 
AC: 
4
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Pathogenic 
Submissions summary: Pathogenic:1 
Revision: no assertion criteria provided
LINK: link 
Submissions by phenotype
Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy    Pathogenic:1 
Nov 14, 2016
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Uncertain 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Uncertain 
D 
 PhyloP100 
 Vest4 
 GERP RS 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.